An Mb1-Cre-driven oncogenic Kras mutation results in a mouse model of T-acute lymphoblastic leukemia/lymphoma with short latency and high penetrance.
Jacob J JuncoTaylor ChenRaushan RashidMaci TerrellVincent U GantMatthew MillerRachel RauH Daniel LacorazzaKaren R RabinPublished in: Leukemia (2020)